drugset / Trial / NCT05058638

Effectiveness of Aquamin® in Mitigating Halitosis

NCT05058638

Phase 2 Active not recruiting 15 enrolled University of Michigan
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess whether Aquamin®, a multi-mineral natural product from red marine algae, can help reduce halitosis when taken for 90 days.

Timeline

Start
2022-08-15
Primary completion
2026-12
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Aquamin Other / unclassified 800 mg